GILLMAN PHARMACEUTICALS
Pharmaceutical company · 17 brands · 20 molecules
Ranked #86 of 156 companies in Antianemic, Iron Preparations
Company overview
GILLMAN PHARMACEUTICALS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 17 product registrations across 20 distinct molecules. Its portfolio is concentrated in Antianemic, Iron Preparations and Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). DRAP has issued 2 alerts involving its products.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Products by GILLMAN
1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.
Top molecules by brand count
Therapeutic classes
Price band (DRAP official ceilings)
Regulatory record
2 alerts in the DRAP feed we track.
Competitive set
Companies whose registered portfolio overlaps most with this one.
Portfolio whitespace
Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.
Get the full profile for GILLMAN
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.
Request this brief See what’s included